Article Details
Retrieved on: 2024-12-08 18:06:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
bluebird bio, Inc. (Nasdaq: BLUE) today announced new and updated data from LYFGENIAâ„¢ (lovotobegligene autotemcel, or lovo-cel) gene therapy for ...
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here